Snow Leopard
Senior Member (Voting Rights)
We've seen plenty of trials like this for other illnesses, they're rarely successful, unfortunately.
It depends on your measure of success, and your point of view.We've seen plenty of trials like this for other illnesses, they're rarely successful, unfortunately.
Could it work like copaxone by offering up a decoy to antibodies
The Guardian article states:
"Further investigation revealed that they were accumulating lactic acid in their muscles at a faster rate than healthy individuals – a possible sign of mitochondrial dysfunction."
Does anyone know which long covid study they might be referring to?
Each AXA1125 stick pack was composed of leucine 1.00 g, isoleucine 0.50 g, valine 0.50 g, arginine HCl 1.81 g, glutamine 2.00 g, and NAC 0.15 g (5.65-g free AA/stick pack)
Different department, probably with no knowledge of Michael Sharpe's involvement in PACE etc.isn’t that amazing that Oxford decided these patients deserve to be researched and deserved clinical trials? Isn’t that out of ordinary that this person has not been gaslit and disbelieved and offered a behavioral treatment?
The research team will be using magnetic resonance spectroscopy to assess any improvements in mitochondrial function within the skeletal muscle in long COVID patients.
Dr Raman also leads the C-MORE study, which tracks COVID-19 patients discharged from hospitals to uncover the long-term effects of the disease, including persistent symptoms, as well as changes in lung and heart function.
Different department, probably with no knowledge of Michael Sharpe's involvement in PACE etc.
I think it's probably more a case of the company that manufactures the product looking for an academic/medical department to conduct a trial.
I had forgotten what a tiny trial this is, only 40 people, half on placebo.
Neither do I. I had assumed this one was being funded by the drug company.i do not hold hope that this trial will make any difference. But we all know that research money is being thrown at Long Covid.
Rice and peas is also a complete protein, which is why it is such a popular food in the Caribbean (and why there are variations on this in countries all over the world).Above in the thread I jokingly commented, when we found out the AXA1125 components, that it sounded a lot like chicken. I checked out the specific animo acids:
"Animal and plant foods that contain complete proteins or all amino acids include: Red meat. Chicken..."
In 100 g of chicken meat (various sources) [in the AXA1125 stick pack]
Leucine 2.00 g vs 1.00 g in AXA1125
Isoleucine 0.375 g vs 0.5g. (1.5g in 100g of beef).
Valine 1.66 g vs 0.5g
Arginine 2.00 g vs 1.81 g
Glutamine 5.00 g vs 2.00 g
NAC is a precursor to cysteine. Cysteine 0.336 g NAC 0.15 g
Basically, if you eat a small serve of animal protein each day and the rest of your diet has dairy food, legumes, vegetables and whole grains, you will be getting so much of the nutrients in AXA1125 that it's hard to imagine this supplement making any difference at all. No doubt a healthy vegetarian diet would do the job too. Sure, not every person with ME/CFS will be eating well, but enough of us have eaten well, at least at times, to know that diet and/or amino acid supplements aren't a cure.
It doesn't sound as though the researchers are controlling for diet. There's no mention of them even asking about diet or requiring diet to be kept constant. When you are investigating a supplement that is a lot like food, I would think it would be important.
And, it's not as if there is something magic in the ratios of the individual components either.
I had a lecturer when I took my advanced genetics course who was very interested in the regulatory potential of long non coding RNA.my understanding is that rare variants almost always occur in the coding region (i.e. affecting the protein that is made, not the quantity of the protein). This is because such protein-coding variants often have large effects. Most variants that turn up in GWAS are in non-coding regions and have small effects.
Sadly pretty commonIt doesn't sound as though the researchers are controlling for diet. There's no mention of them even asking about diet or requiring diet to be kept constant. When you are investigating a supplement that is a lot like food, I would think it would be important.
I do not believe there is proven physical mitochondria damage. Anyone heard otherwise?The idea is that it can give the mitochondria additional fuel to produce energy, and help repair damaged mitochondria.
I do not believe there is proven physical mitochondria damage. Anyone heard otherwise?
Agreed, and those are metabolic differences but no physical damage showing in electron microscopy.Possibly some evidence of changes in mitochondrial energy/fuel usage but even if this is true it surely looks like a downstream effect rather than primary cause.
Chris Armstrong's work (2015) indicated a change in mitochondrial "fuel" usage - glucose high (less utilisation) and some amino acids low (increased utilisation). Fluge & Mella potentially found evidence of PDH not functioning [cytric acid cycle - mitochondrial energy cycle?] i.e. amino acids which don't go through PDH were low and amino acids which do were elevated. Ron Davis's recent grant on manganese seems to be linked to this i.e. changes in energy production [related to manganese?] and downstream effect of increasing utilisation of amino acids for energy production.
Not exactly, they found that pwME had an increase in PDK's, which are enzymes that add methyl groups to PDH and inactivates it. So PDH is actually working as it should, but the regulatory mechanism is out of whack. The question is why this happens.Fluge & Mella potentially found evidence of PDH not functioning [cytric acid cycle - mitochondrial energy cycle?] i.e. amino acids which don't go through PDH were low and amino acids which do were elevated.